Exploration of Sorafenib Influences on Gene Expression of Hepatocellular Carcinoma

Huancheng Wang1, Jia Liu1

  • 1First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.

Frontiers in Genetics
|November 2, 2020
PubMed
Abstract

Insights

This study identifies key gene expression changes in hepatocellular carcinoma (HCC) patients treated with sorafenib. These findings offer insights into sorafenib

Area of Science:

  • Oncology
  • Genomics
  • Pharmacogenomics

Background:

  • Hepatocellular carcinoma (HCC) is a significant global health concern.
  • Sorafenib is a crucial targeted therapy for advanced HCC.
  • Understanding the molecular mechanisms of sorafenib is vital for optimizing treatment.

Purpose of the Study:

  • To establish a comprehensive differential gene expression profile for HCC patients undergoing sorafenib treatment.
  • To identify potential molecular targets and biomarkers associated with sorafenib efficacy and side effects in HCC.

Main Methods:

  • RNA and miRNA sequencing data from 114 sorafenib-treated HCC patients and 326 untreated controls were analyzed.
  • Differential expression analysis, functional enrichment (GO, KEGG), and protein-protein interaction analyses were performed.
  • Key gene and miRNA candidates were validated using ELISA in clinical HCC samples.

Main Results:

  • 66 differentially expressed genes (DEGs) and 3 differentially expressed miRNAs (DEMs) were identified in sorafenib-treated HCC patients.
  • Five genes (HTR2C, TRH, AGTR2, MCHR2, SLC6A2) and three miRNAs (hsa-miR-4445, hsa-miR-466, hsa-miR-2114) were proposed as potential sorafenib targets.
  • Functional enrichment analysis revealed significant biological processes, cellular components, and molecular functions affected by sorafenib.

Conclusions:

  • The identified differential gene expression profile provides a deeper understanding of sorafenib's action in HCC.
  • This research highlights potential therapeutic targets and clinical biomarkers for sorafenib in HCC treatment.
  • Findings may aid in mitigating sorafenib's side effects and improving patient outcomes.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.3K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
15.2K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
118
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
394
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.3K